| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Modified Organism
Oilseed rape modified for an altered fatty acid metabolism in the seeds
Record information and status
Record ID
110921
Status
Published
Date of creation
2016-09-12 10:35 UTC (german_bch@bvl.bund.de)
Date of publication
2016-09-20 16:26 UTC (dina.abdelhakim@cbd.int)

This document is also available in the following languages:
Living Modified Organism identity
The image below identifies the LMO through its unique identifier, trade name and a link to this page of the BCH. Click on it to download a larger image on your computer. For help on how to use it go to the LMO quick-links page.

LMO name
Oilseed rape modified for an altered fatty acid metabolism in the seeds
Transformation event
Independent transgenic lines transformed with pALM1
Developer(s)
DSV
Deutsche Saatveredelung AG (DSV)
Weissenburger Straße 5
59557 Lippstadt
Lippstadt
Germany, 59557
Phone:+49 2941 2960
Fax:+49 2941 296100
Email:info@dsv-saaten.de
Url:https://www.dsv-saaten.de/
Description
In the genetically modified oilseed rape plants lysophosphatidic acid acyltransferase from Limnanthes douglasii, which catalyses the linkage of erucic acid to the sn-2 position of lysophosphatidic acid, is expressed specifically in the seeds. As a result of the modification the production of trierucin is expected in the seeds, therefore increasing their erucic acid content.

Simultaneously, the oilseed rape plants are also transformed with an antisense construct of the native lysophosphatidic acid acyltransferase gene leading to a reduction in the expression of the endogenous gene, thereby reducing the linkage of unspecific fatty acids to the sn-2 position of lysophosphatidic acid.
Recipient Organism or Parental Organisms
The term Recipient organism refers to an organism (either already modified or non-modified) that was subjected to genetic modification, whereas Parental organisms refers to those that were involved in cross breeding or cell fusion.
Brassica napus - Turnip, Rapeseed, Canola Plant, Oilseed Rape, Rape, BRANA
Related LMOs
Brassica napus modified for altered fatty acid metabolism
BAZ Changes in quality and/or metabolite content - Lipid and fatty acids Resistance to antibiotics - Kanamycin
Oilseed rape modified for an altered fatty acid metabolism in the seeds
DSV Changes in quality and/or metabolite content - Lipid and fatty acids Resistance to antibiotics - Kanamycin
Oilseed rape modified for an altered fatty acid metabolism in the seeds
DSV Changes in quality and/or metabolite content - Lipid and fatty acids Resistance to antibiotics - Kanamycin
Oilseed rape modified for an altered fatty acid metabolism in the seeds
DSV Changes in quality and/or metabolite content - Lipid and fatty acids Resistance to antibiotics - Kanamycin
Oilseed rape modified for an altered fatty acid metabolism in the seeds
DSV Changes in quality and/or metabolite content - Lipid and fatty acids Resistance to antibiotics - Kanamycin
Oilseed rape modified for an altered fatty acid metabolism in the seeds
DSV Changes in quality and/or metabolite content - Lipid and fatty acids Resistance to antibiotics - Kanamycin
Oilseed rape modified for an altered fatty acid metabolism in the seeds
DSV Changes in quality and/or metabolite content - Lipid and fatty acids Resistance to antibiotics - Kanamycin
Oilseed rape modified for an altered fatty acid metabolism in the seeds
DSV Changes in quality and/or metabolite content - Lipid and fatty acids Resistance to antibiotics - Kanamycin
Characteristics of the transformation process
Vector
pALM1
Techniques used for the modification
  • Agrobacterium-mediated DNA transfer
Genetic elements construct
 
Napin gene promoter
0.00 Kb
 
 
1-acyl-sn-glycerol-3-phosphate acyltransferase coding sequence
0.00 Kb
 
 
Napin gene terminator
0.00 Kb
 
 
Napin gene promoter
0.00 Kb
 
 
1-acyl-sn-glycerol-3-phosphate acyltransferase coding sequence
0.00 Kb
 
 
Acyl-acyl carrier protein thioesterase Terminator
0.00 Kb
 
 
CaMV 35S promoter
0.00 Kb
 
 
Neomycin Phosphotransferase II
0.00 Kb
 
 
CaMV 35S terminator
0.00 Kb
 
Further details
LMO characteristics
Modified traits
Common use(s)
  • Research
Additional Information
Other relevant website address or attached documents

Records referencing this document (9)
IDDescription
9record(s) found
Country's Decision or any other Communication1 record
Modified Organism7 records
Risk Assessment1 record